The DES Center

Filter Your Results

 

News

 

Reva Medical's Fantom Bioresorbable Coronary Scaffold Approved in Europe

April 10, 2017 -- Reva Medical, Inc. announced it has received European CE Mark approval for its Fantom drug-eluting bioresorbable coronary scaffold. Fantom is Reva’s fi…

ECLIPSE Trial of CSI's Orbital Atherectomy System Begins Enrollment

March 28, 2017 -- Cardiovascular Systems, Inc. (CSI), in partnership with the Cardiovascular Research Foundation, announced the commencement of enrollment in the ECLIPSE clini…

PROTECT Evaluates DES Implantation in Left Anterior Descending Artery

March 27, 2017 -- Ariel Roguin, MD, et al published long-term outcomes of the PROTECT (Patient Related Outcomes with Endeavor Versus Cypher Stenting Trial) trial in …

BIOFLOW-IV Data Presented in Japan for Biotronik's Orsiro DES

March 23, 2017 -- Biotronik announced that 12-month results of the BIOFLOW-IV clinical study of the company's Orsiro hybrid drug-eluting stent (DES) were presented at the …

Abbott Vascular's 2-Year ABSORB III Data Presented; FDA Issues Warning Letter

March 18, 2017 -- Abbott Vascular announced that data from ABSORB III, the company's United States pivotal trial of its Absorb bioresorbable vascular scaffold, showed…

Biosensors’ LEADERS FREE II BioFreedom Pivotal Study Begins Enrollment

February 15, 2017 -- Biosensors International Group, Ltd. announced that it has started enrollment in the new BioFreedom pivotal study, called LEADERS FREE II. The study …

Five-Year Data Published From Medtronic's RESOLUTE Global Clinical Trial Program

February 9, 2017 -- Five-year safety and efficacy data from the RESOLUTE Global clinical trial program were published online by Robert W. Yeh, MD, et al in Journal of the…

Alvimedica's Cre8 Evo DES Receives CE Mark Approval

February 8, 2017 -- Alvimedica recently announced European CE Mark approval of its Cre8 Evo amphilimus-eluting stent, which is manufactured by CID SpA, a member of Alvime…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.